What is the average weight loss for overweight patients without diabetes using semaglutide?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18771826
Cited by: 0

Abstract

Semaglutide is associated with significant weight loss in overweight or obese patients without diabetes, with average reductions in body weight reported between 11% and 14% in clinical trials.

Fields of Study & Subjects

Pharmacology and Obesity Treatment Diabetes Treatment and Management Regulation of Appetite and Obesity

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
25 February 2026
Language
EN